← Evidence map

ArticleNature reviews. Endocrinology2023

Approval of teplizumab: implications for patients.

Cate Speake et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 37202589